G. Zagars

Malignant Peripheral Nerve Sheath Tumors: A Single Institution’s Experience Using Combined Surgery and Radiation Therapy
201641 citationsauthor #2
Treatment-related fractures after combined modality therapy for soft tissue sarcomas of the proximal lower extremity: Can the risk be mitigated?
201626 citationsauthor #2
Soft Tissue Solitary Fibrous Tumor: Combined Surgery and Radiation Therapy Results in Excellent Local Control
201554 citationsauthor #2
Combined Limb-Sparing Surgery and Radiation Therapy to Treat Sarcomas of the Hands and Feet: Long-Term Cancer Outcomes and Morbidity.
201511 citationsauthor #2
Estimating the Risk of Femur Fracture Among Patients Treated for Soft-Tissue Sarcomas of the Lower Extremity: A Series of 749 Patients
20150 citationsauthor #2
Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients.
201525 citationsauthor #2
The role of adjuvant radiotherapy in the local management of desmoplastic melanoma
201480 citationsauthor #5
Clinical Investigation : Sarcoma Dermatofibrosarcoma Protuberans : Long-term Outcomes of 53 Patients Treated With Conservative Surgery and Radiation Therapy
201359 citationsauthor #5
A Population-Based Study of the Quality of Care in the Diagnosis of Large (≥5 cm) Soft Tissue Sarcomas
20127 citationsauthor #3
Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.
201214 citationsauthor #5
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
201225 citationsauthor #15
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp
2011164 citationsauthor #2
Sphincter‐sparing local excision and hypofractionated radiation therapy for anorectal melanoma
201181 citationsauthor #2
Chapter 36 – The Soft Tissue
20100 citationsauthor #2
Chapter 3 – Principles of Combining Radiation Therapy and Surgery
20100 citationsauthor #1
Sphincter-sparing Local Excision and Hypofractionated Radiation Therapy for Anal-rectal Melanoma: A 20 Year Experience
201031 citationsauthor #5
Sphincter-sparing Local Excision and Hypofractionated Radiation Therapy for Anal-rectal Melanoma: A
20100 citationsauthor #5
Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: A critical assessment
20096 citationsauthor #3
Osteosarcoma of the jaw/craniofacial bones: Outcomes following multimodality treatment.
20091 citationsauthor #2
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
200946 citationsauthor #9
Osteosarcoma of the jaw/craniofacial region
2009188 citationsauthor #2
Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma.
200946 citationsauthor #2
Radiation Treatment Field Delineation for Axillary Metastases from Malignant Melanoma
20081 citationsauthor #8
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.
2008111 citationsauthor #2
Long-term outcomes for desmoid tumors treated with radiation therapy.
2008149 citationsauthor #2
Mortality after cure of soft‐tissue sarcoma treated with conservation surgery and radiotherapy
200812 citationsauthor #2
Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy.
200773 citationsauthor #9
Long-term Results of Prospective Trial of Surgery Alone With Selective Use of Radiation for Patients With T1 Extremity and Trunk Soft Tissue Sarcomas
2007135 citationsauthor #10
Optimizing treatment of desmoid tumors.
2007277 citationsauthor #5
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.
2007154 citationsauthor #2
Periosteal margin in soft‐tissue sarcoma
200746 citationsauthor #10
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy.
200792 citationsauthor #2
214 : The Role of Re-irradiation in the Management of Locally Recurrent Soft Tissue Sarcoma After Prior Surgery and Radiation Therapy
20060 citationsauthor #9
Combined-modality therapy for patients with regional nodal metastases from melanoma.
200685 citationsauthor #8
Complications of combined modality treatment of primary lower extremity soft‐tissue sarcomas
2006189 citationsauthor #3
The Effect of Preoperative Radiotherapy and Reconstructive Surgery on Wound Complications after Resection of Extremity Soft-Tissue Sarcomas
2006101 citationsauthor #12
Combined modality therapy for patients with nodal metastases from melanoma
20050 citationsauthor #7
The Clinical Impact of Local Radiation Therapy and the Percentage of Positive Lymph Nodes in Prostate Cancer Patients Treated with Hormonal Therapy
20050 citationsauthor #5
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
200476 citationsauthor #13
Mortality after cure of testicular seminoma.
2004284 citationsauthor #1
A Critical Assessment of Adjuvant Radiotherapy for Inguinal Lymph Node Metastases from Melanoma
200459 citationsauthor #2
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma.
200461 citationsauthor #2
In response to Drs. Millar and Williams
20030 citationsauthor #2
Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
2003173 citationsauthor #2
The length of time between surgery and post-operative radiotherapy and local control for soft tissue sarcoma
20032 citationsauthor #2
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome.
2003138 citationsauthor #1
Radiotherapy in the management of giant cell tumor of bone.
200396 citationsauthor #3
Comment on: Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Authors' reply
20030 citationsauthor #4
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy
2003201 citationsauthor #1
Significance of dose in postoperative radiotherapy for soft tissue sarcoma.
200397 citationsauthor #1
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.
2003141 citationsauthor #8
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study.
200349 citationsauthor #4
Radiation therapy for soft tissue sarcoma.
200324 citationsauthor #2
In response to Drs. Kagan and Schulz
20030 citationsauthor #2
Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy
2003539 citationsauthor #1
Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned.
200322 citationsauthor #1
The follow-up of adult soft-tissue sarcomas.
200340 citationsauthor #2
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy.
2003134 citationsauthor #1
Adjuvant irradiation for cervical lymph node metastases from melanoma
2003118 citationsauthor #7
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma
2003106 citationsauthor #4
A commentary on: Dose escalation and bned in prostate cancer. Authors' reply
20030 citationsauthor #4
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
2002134 citationsauthor #3
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer.
200221 citationsauthor #3
Adult rhabdomyosarcoma
2002169 citationsauthor #3
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.
2002155 citationsauthor #2
Surgical management of soft tissue sarcomas of the hand and foot
2002117 citationsauthor #4
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.
200295 citationsauthor #4
Extraosseous osteosarcoma: response to treatment and long-term outcome.
2002105 citationsauthor #12
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer.
2001115 citationsauthor #1
Epithelioid sarcoma: results of conservative surgery and radiotherapy.
200194 citationsauthor #8
Spermatic cord sarcoma: outcome, patterns of failure and management.
2001142 citationsauthor #2
Concurrent ifosfamide‐based chemotherapy and irradiation
200135 citationsauthor #9
Radiotherapy for stage II testicular seminoma.
200160 citationsauthor #1
Adjuvant irradiation for axillary metastases from malignant melanoma.
2001102 citationsauthor #3
Adult rhabdomyosarcoma: Outcome and prognostic factors
20010 citationsauthor #3
Relationship of prostate biopsy status to radiotherapy dose, PSA nadir level and outcome in participants of a randomized dose escalation trial for prostate cancer
20014 citationsauthor #2
Molecular markers of patient outcome in prostate cancer treated with radiotherapy: Ki-67, Bcl-2, Bax, and Bcl-x
20011 citationsauthor #4
The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
200028 citationsauthor #6
Minisatellite mutation frequency in human sperm following radiotherapy.
200068 citationsauthor #5
Primary treatment of cystosarcoma phyllodes of the breast
2000400 citationsauthor #4
Serum testosterone is not a correlate of prostate cancer lymph node involvement, but does predict biochemical failure for lymph node positive disease.
20001 citationsauthor #3
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer.
2000541 citationsauthor #2
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.
2000423 citationsauthor #3
Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.
1999481 citationsauthor #2
Long-Term O utcome o f P atients W ith A merican J oint Committee o n C ancer S tage I IB E xtremity Soft T issue S arcomas
19990 citationsauthor #14
Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation.
199922 citationsauthor #2
4 Preliminary results of a randomized dose-escalation study comparing 70 GY to 78 GY for the treatment of prostate cancer
199932 citationsauthor #2
Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate.
199957 citationsauthor #1
139 Predictors of distant metastasis 7 years after a rising PSA in prostate cancer patients treated with external beam radiotherapy
19995 citationsauthor #3
2130 Family history in prostate cancer: Outcome analysis of hereditary versus familial prostate cancer following definitive radiation therapy
19990 citationsauthor #2
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.
199960 citationsauthor #14
Relationship of Ki‐67 labeling index to DNA‐ploidy, S‐phase fraction, and outcome in prostate cancer treated with radiotherapy
199946 citationsauthor #7
Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy
199927 citationsauthor #4
Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.
199928 citationsauthor #2
Desmoid tumor outcome following radiation therapy with and without surgical resection
19983 citationsauthor #2
Regarding zagars and pollack [4] (multiple letters)
19981 citationsauthor #2
Radiation therapy in the management of desmoid tumors.
1998144 citationsauthor #2
Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
199812 citationsauthor #5
Early androgen ablation and radiation therapy for unfavorable local-regional prostate cancer
19980 citationsauthor #1
Pretreatment serum testosterone as a prognostic factor in patients with node positive prostate cancer treated with androgen ablation
19981 citationsauthor #3

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT